Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists (news.ycombinator.com)
2.
People Jabbing Themselves With Black Market “GLP-3” Drugs (futurism.com)
3.
A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk (cnet.com)
4.
Costco Is Now Selling Ozempic and Other GLP-1 Drugs. These Are the Benefits and Risks You Need to Know (cnet.com)
5.
Ozempic and Other GLP-1s: Know the Benefits, Risk Factors and Overdose Info (cnet.com)
6.
NMDA Receptor Antagonists: Slightly More Than You Wanted to Know (news.ycombinator.com)
Today's top topics: nasa artemis ii moon mission orion spacecraft san diego splashdown orion capsule space mission
View all today's topics →